Eric Ross is the Chief Executive Officer at Proxima Clinical Research, a contract research organization that serves the emerging drug and medical device industries. At Proxima, Ross leads the company's mission to support MedTech and Biotech companies in obtaining regulatory approval and improving patient outcomes.
Prior to joining Proxima, Ross held multiple C-Level, Executive, and Management roles at CRO and eclinical organizations. His past experience includes Business Development growth at Chiltern, Ockham Oncology, and various Director and Manager roles at Almac and etrials Worldwide. These companies provided a background that included a mix of large and niche CRO’s as well as clinical trial technology companies with EDC, IVR, and ePRO products. In addition to Business Development, Eric held roles in multiple departments including significant time in Operations as a Project Manager, Product Manager, and Director of Global Support Services.
University of North Carolina at Chapel Hill: B.A.
TORO Clinical, Austin, Texas
Chief Commercial Officer (CCO)
TD2 Oncology, Remote
VP Business Development
Aperio Clinical Outcomes, Durham, North Carolina
Chief Commercial Officer (CCO)
VP, Business Development
MedSource (now Ergomed), Raleigh-Durham-Chapel Hill Area
VP, Business Development
Senior Director, Business Development
Chiltern, Raleigh-Durham, North Carolina Area
Director Business Development, Oncology
Almac Group, Lansdale, Pa.
Product Manager, Patient Management
ePRO Manager
Merge Healthcare, Morrisville, N.C.
Director Global Support Services
Project Manager II
etrials Worldwide, Morrisville, N.C.
Project Manager I
eDiary / ePro Lead Specialist
Global Support Specialist
Eric has multiple published research presentations including Patient Preferences for Reminders in Clinical Trials: Improving both Compliance and Patient Experience; Which ePRO Modality is Appropriate for your Study?; and Converting Paper Versions of Patient Reported Outcome Instruments to Electronic Versions: Identifying the Required Steps.
